LAB financials
Standard BioTools (LAB) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- LAB revenue was $85.33M in fiscal 2025, net income -$74.90M.
LAB income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $85.33M | $42.54M | -$110.25M | -$74.90M | -0.20 |
| 2024 | $91.01M | $44.88M | -$127.48M | -$184.90M | -0.52 |
| 2023 | $106.34M | $50.45M | -$76.60M | -$74.66M | -0.94 |
| 2022 | $97.95M | $37.05M | -$116.20M | -$190.10M | -2.43 |
| 2021 | $130.58M | $69.37M | -$67.46M | -$59.24M | -0.78 |
| 2020 | $138.14M | $83.33M | -$51.04M | -$53.02M | -0.74 |